Synthesis and Biological Evaluation of Substituted 2-anilino-7H-pyrrolopyrimidines as PDK1 Inhibitors
This article was originally published as:
O'Brien, N. J., Brzozowski, M., Wilson, D. J., Deady, L. W., & Abbott, B. M. (2014). Synthesis and biological evaluation of substituted 2-anilino-7H-pyrrolopyrimidines as PDK1 inhibitors. Tetrahedron, 70(33), 4947-4956. doi:10.1016/j.tet.2014.05.033
An efficient and scalable route for a series of novel substituted 2-anilino-7H-pyrrolopyrimidine compounds as potential inhibitors of PDK1, an important regulator of the PI3K/Akt pathway that is dysregulated in many cancers, was developed and is described. The synthetic strategy was designed around Suzuki and BuchwaldeHartwig cross-couplings of a boronate fragment and various customised anilines sequentially with 2,4-dichloro-7-tosyl-7H-pyrrolopyrimidine. All fragments were constructed separately and cross-coupled to provide access to a range of novel compounds. Biological evaluation of these was undertaken, with modest inhibition observed.
O'Brien, Nathan J.; Brzozowski, Martin; Wilson, David J.; Deady, Leslie W.; and Abbott, Belinda M., "Synthesis and Biological Evaluation of Substituted 2-anilino-7H-pyrrolopyrimidines as PDK1 Inhibitors" (2014). Science and Mathematics Papers and Journal Articles. 64.